VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults

Conditions:   Invasive Aspergillosis;   Invasive Pulmonary Aspergillosis Interventions:   Drug: Investigational Agent: VL-2397;   Drug: Standard treatment: Voriconazole, Isavuconazole, or Liposomal amphotericin B Sponsor:   Vical Not yet recruiting

Source: ClinicalTrials.gov - October 31, 2017 Category: Research Source Type: clinical trials